SCHEMATIC OVERVIEW OF P2Y2 SIGNALING IN CANCER, INCLUDING MOLECULAR MECHANISMS, TUMOR MICROENVIRONMENT REPROGRAMMING, IMMUNE EVASION, THERAPEUTIC RESISTANCE, AND DIGITAL MEDICINE APPROACHES. (IMAGE)

KeAi Communications Co., Ltd.

SCHEMATIC OVERVIEW OF P2Y2 SIGNALING IN CANCER, INCLUDING MOLECULAR MECHANISMS, TUMOR MICROENVIRONMENT REPROGRAMMING, IMMUNE EVASION, THERAPEUTIC RESISTANCE, AND DIGITAL MEDICINE APPROACHES.

Caption

SCHEMATIC OVERVIEW OF P2Y2 SIGNALING IN CANCER, INCLUDING MOLECULAR MECHANISMS, TUMOR MICROENVIRONMENT REPROGRAMMING, IMMUNE EVASION, THERAPEUTIC RESISTANCE, AND DIGITAL MEDICINE APPROACHES.

Credit

Wanjin Hong and Gandhi T. K. Boopathy

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.